Superworth

Haemonetics price to book ratio HAE

Market value divided by the book value of the company's net assets, since 2010.

Today, Oct 23, 2026
6.4×
10-year median
4.8×
Against its 10-year history
71st
percentile: 0 is its lowest day, 100 its highest
10-year range
2.4× to 11.9×
Peer median
4.5×

Haemonetics' price to book ratio is 6.4× as of Oct 23, 2026.

That is above its ten-year median of 4.8×, higher than on 71% of days in the last ten years.

Over that time it ranged from 2.4× in Oct 2016 to 11.9× in Aug 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 4.5×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far6.4×2.8×6.5×
20254.4×2.6×4.6×
20244.4×3.9×5.2×
20234.9×4.7×6.2×
20225.5×3.4×6.0×
20213.9×3.8×9.8×
20209.0×6.6×10.6×
201910.1×6.5×11.9×
20187.1×4.1×8.8×
20173.8×2.5×3.9×
20162.8×1.8×2.8×
20152.1×2.0×2.8×
20142.4×2.0×2.7×
20132.8×2.5×3.0×
20122.7×2.3×2.8×
20112.3×2.0×2.8×
20102.6×2.3×2.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Haemonetics' size, closest first, today.

CompanyPrice to book ratio
HAEHaemonetics6.4×
MMSIMerit Medical Systems3.3×
VNTVontier3.9×
BMIBadger Meter6.4×
ICUIICU Medical1.9×
MSAMSA Safety5.0×
NVSTEnvista1.2×
WRBYWarby Parker8.2×
ATRCAtriCure5.8×
PODDInsulet7.3×
GMEDGlobus Medical2.3×
Peer median4.5×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Haemonetics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.